Total Valuation
Anbio Biotechnology Class A has a market cap or net worth of $1.42B. The enterprise value is $688.35M.
Market Cap$1.42B
Enterprise Value$688.35M
Share Statistics
Anbio Biotechnology Class A has 43,891,200 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding43,891,200
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Anbio Biotechnology Class A’s return on equity (ROE) is 0.21 and return on invested capital (ROIC) is 19.13%.
Return on Equity (ROE)0.21
Return on Assets (ROA)0.21
Return on Invested Capital (ROIC)19.13%
Return on Capital Employed (ROCE)0.19
Revenue Per Employee320.25K
Profits Per Employee237.17K
Employee Count27
Asset Turnover0.29
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of Anbio Biotechnology Class A is 51.2. Anbio Biotechnology Class A’s PEG ratio is 1.01.
PE Ratio51.2
PS Ratio152.63
PB Ratio43.77
Price to Fair Value43.77
Price to FCF-195.84
Price to Operating Cash Flow0.00
PEG Ratio1.01
Income Statement
In the last 12 months, Anbio Biotechnology Class A had revenue of 8.65M and earned 6.40M in profits. Earnings per share was 0.16.
Revenue8.65M
Gross Profit7.54M
Operating Income5.77M
Pretax Income6.40M
Net Income6.40M
EBITDA5.77M
Earnings Per Share (EPS)0.16
Cash Flow
In the last 12 months, operating cash flow was 0.00 and capital expenditures 0.00, giving a free cash flow of 0.00 billion.
Operating Cash Flow0.00
Free Cash Flow0.00
Free Cash Flow per Share0.00
Dividends & Yields
Anbio Biotechnology Class A pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.40
52-Week Price Change-76.76%
50-Day Moving Average26.29
200-Day Moving Average―
Relative Strength Index (RSI)65.59
Average Volume (3m)45.02K
Important Dates
Anbio Biotechnology Class A upcoming earnings date is ―, ―.
Last Earnings Date―
Next Earnings Date―
Ex-Dividend Date―
Financial Position
Anbio Biotechnology Class A as a current ratio of 344.31, with Debt / Equity ratio of 0.00%
Current Ratio344.31
Quick Ratio344.31
Debt to Market Cap0.00
Net Debt to EBITDA-1.35
Interest Coverage Ratio0.00
Taxes
In the past 12 months, Anbio Biotechnology Class A has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
Anbio Biotechnology Class A EV to EBITDA ratio is 227.48, with an EV/FCF ratio of -194.69.
EV to Sales151.74
EV to EBITDA227.48
EV to Free Cash Flow-194.69
EV to Operating Cash Flow-194.69
Balance Sheet
Anbio Biotechnology Class A has $11.90M in cash and marketable securities with $0.00 in debt, giving a net cash position of $11.90M billion.
Cash & Marketable Securities$11.90M
Total Debt$0.00
Net Cash$11.90M
Net Cash Per Share$0.27
Tangible Book Value Per Share$0.69
Margins
Gross margin is 86.10%, with operating margin of 66.70%, and net profit margin of 74.06%.
Gross Margin86.10%
Operating Margin66.70%
Pretax Margin74.06%
Net Profit Margin74.06%
EBITDA Margin66.70%
EBIT Margin66.70%
Analyst Forecast
The average price target for Anbio Biotechnology Class A is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast10.10%
EPS Growth Forecast170.13%